Clinical analysis of thrombolytic therapy with ischemic in-hospital stroke / 中国神经精神疾病杂志
Chinese Journal of Nervous and Mental Diseases
; (12): 4-7, 2017.
Article
in Zh
| WPRIM
| ID: wpr-510914
Responsible library:
WPRO
ABSTRACT
Objective To analyze the clinical effects of thrombolytic therapy in patients with ischemic in-hos-pital stroke (IHS). Methods The clinical data were collected from patients with ischemic IHS in the last five years. The patients were divided into thrombolysis group and non-thrombolysis group, according to the use of recombinant tissue plasminogen activator (r-tPA) treatment. The clinical outcomes were measured by the modified Rankin scale (mRS) at discharge. Results There were a total of 121 patients in this study. There were 6 patients in thrombolysis group and 115 patients in the non-thrombolysis group, respectively. Six patients (100%) in the thrombolysis group achieved favor-able outcomes (mRS 0~2) at discharge whereas only 42 patients (36.5%) in the non-thrombolysis group achieved fa-vourable outcomes. The rate of favorable outcomes was significantly higher in the thrombolysis group than in the non-thrombolysis group (P<0.05). Conclusions R-tPA thrombolytic therapy can improve the prognosis of patients with ischemic IHS.
Full text:
1
Index:
WPRIM
Language:
Zh
Journal:
Chinese Journal of Nervous and Mental Diseases
Year:
2017
Type:
Article